Citizens, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
~$6.8
Valuation models combined (3)
Base case. Range ~$6.5–$7.6. Weighted average of 3 models (residual income, justified price-to-book, price-to-book vs return on equity (peers)), the residual income counting double.
Undervalued
The price is below our entire value range; our base value is 82% above it.
Price used: $3.72, November 2, 2026
Citizens, Inc. valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to June 2026 was $255m, up 3.7% on a year earlier, slower than the 6.9% growth a quarter earlier. Our cash-flow model value is $6.62 a share, against a share price of $3.87.
Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Citizens, Inc.'s trailing-twelve-month revenue grew 3.7% year on year, with a free-cash-flow margin of 5.9%. Where it lags: change in growth rate of -3.2pp ranks 15 of 18 life & health insurance companies we cover.
Current signal Free cash flow diverging from earnings: TTM free cash flow fell 37.6% while net income grew 3.1%: a 41pp divergence.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
We value Citizens, Inc. as an insurer, with every model that fits that kind of business. Cost of equity 9.2%: the 10-year Treasury yield (4.9%) plus a beta of 0.95 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$6.5 ~$4.3–$9.9 | Primary model, counts double |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$6.5 ~$5.6–$7.8 | Included |
| Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. | ~$7.6 ~$4.4–$11 | Included |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$0.0 ~$3.2–$9.5 | Left out: out of range vs price (0.01x) |
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | ~$0.0 ~$1.8–$3.9 | Left out: out of range vs price (0.01x) |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | — | Does not apply: pays no regular dividend |
| Combined value Weighted average of the models that apply: the primary model (residual income) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$6.8 ~$6.5–$7.6 | 3 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Citizens, Inc. with life and health insurers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Next results: November 5, 2026, after the close. Analysts expect revenue of $65m and EPS of $0.03 (range $0.03 to $0.03) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $0.12 | −57% | $256m | +0% |
| Next | $0.20 | +67% | $267m | +4% |
Next year's EPS estimate has moved −44.4% in 90 days, across 1 analysts.
The consensus EPS forecast for the current fiscal year is −60.0% on 90 days ago. In the last 30 days, 0 analysts raised Citizens, Inc.'s forecast and 1 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $0.30 | $0.36 |
| 60 days ago | $0.30 | $0.36 |
| 30 days ago | $0.30 | $0.36 |
| 7 days ago | $0.30 | $0.36 |
| Now | $0.12 | $0.20 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | $0.07 | $0.01 | −85.7% |
| Mar 2026 | $0.05 | $0.03 | −40.0% |
| Dec 2025 | $0.08 | $0.11 | +37.5% |
| Sept 2025 | $0.06 | $0.07 | +16.7% |
Adjusted EPS as companies report it, against the average analyst estimate.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| CIA | −7% | −60% | +26% | +49% | +20% | −23% |
| Industry peers (median) | +20% | −3% | +19% | +26% | +9% | +15% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| CIA | 67% | 25% | 75% | 58% | 42% | 46% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| CIA | −30% | −63% | −54% | −36% | −42% | −47% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 2, 2015: 86% from December 19, 2016 to May 9, 2023. Getting back needed a 592% gain, and the shares have not yet recovered.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| August 6, 2026 | −18.3% | +0.5% | −16.1% | −15.1% |
| May 7, 2026 | −6.8% | +0.5% | −6.4% | −5.7% |
| March 12, 2026 | −10.4% | −2.1% | −9.4% | +9.4% |
| November 7, 2025 | +6.3% | +1.7% | −2.3% | −16.2% |
| August 7, 2025 | +9.3% | +0.7% | +21.2% | +28.9% |
| May 8, 2025 | −0.8% | +0.6% | +7.9% | −3.9% |
| March 13, 2025 | +4.0% | +0.7% | +17.1% | −10.9% |
| November 7, 2024 | −7.2% | +1.2% | −11.7% | −18.4% |
| August 6, 2024 | +5.0% | +0.2% | +14.2% | +28.5% |
| May 7, 2024 | +2.6% | +0.1% | +10.4% | +28.6% |
| March 14, 2024 | −5.2% | −0.9% | −14.3% | −13.5% |
| November 6, 2023 | −4.0% | +0.5% | +4.0% | +5.9% |
How Citizens, Inc.’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.
Not offered: fundamentals grade none (needs B+ or better).
We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.
Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.
For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.
Not offered: the shares trade below our fair value: a collar caps upside the model expects.
For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.
General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q3 | $241.1M |
| FY23 Q4 | $240.7M |
| FY24 Q1 | $242.5M |
| FY24 Q2 | $246M |
| FY24 Q3 | $248.4M |
| FY24 Q4 | $245M |
| FY25 Q1 | $242.9M |
| FY25 Q2 | $245.9M |
| FY25 Q3 | $247M |
| FY25 Q4 | $255.6M |
| FY26 Q1 | $259.7M |
| FY26 Q2 | $255M |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q3 | 2.5% |
| FY23 Q4 | 3.5% |
| FY24 Q1 | 4.0% |
| FY24 Q2 | 3.4% |
| FY24 Q3 | 3.0% |
| FY24 Q4 | 1.8% |
| FY25 Q1 | 0.2% |
| FY25 Q2 | -0.0% |
| FY25 Q3 | -0.5% |
| FY25 Q4 | 4.3% |
| FY26 Q1 | 6.9% |
| FY26 Q2 | 3.7% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY23 Q3 | 13.4% |
| FY23 Q4 | 9.0% |
| FY24 Q1 | 8.7% |
| FY24 Q2 | 8.4% |
| FY24 Q3 | 10.9% |
| FY24 Q4 | 12.8% |
| FY25 Q1 | 10.4% |
| FY25 Q2 | 9.8% |
| FY25 Q3 | 7.8% |
| FY25 Q4 | 6.9% |
| FY26 Q1 | 6.3% |
| FY26 Q2 | 5.9% |
| Fiscal year | 2009 Dec 2009 | 2010 Dec 2010 | 2011 Dec 2011 | 2012 Dec 2012 | 2013 Dec 2013 | 2014 Dec 2014 | 2015 Dec 2015 | 2016 Dec 2016 | 2017 Dec 2017 | 2018 Dec 2018 | 2019 Dec 2019 | 2020 Dec 2020 | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 | LTM Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 189 | 190 | 194 | 203 | 214 | 230 | 236 | 245 | 253 | 244 | 251 | 239 | 251 | 233 | 241 | 245 | 256 | 255 |
| Net income | 17 | 15 | 8 | 5 | 5 | −6 | −3 | 2 | −38 | −11 | −1 | −11 | 73 | 26 | 24 | 15 | 15 | 12 |
| Growth (year on year) | ||||||||||||||||||
| Revenue | — | +0.7% | +2.0% | +4.4% | +5.4% | +7.8% | +2.6% | +3.9% | +2.9% | −3.4% | +2.7% | −4.7% | +4.9% | −7.2% | +3.5% | +1.8% | +4.3% | +3.7% |
| Net income | — | −15.2% | −42.3% | −46.6% | +5.8% | −224.6% | — | — | — | — | — | — | — | −64.2% | −6.0% | −39.0% | −2.2% | +3.1% |
| Margins | ||||||||||||||||||
| Net margin | 9.2% | 7.7% | 4.4% | 2.2% | 2.2% | −2.6% | −1.3% | 0.8% | −15.1% | −4.5% | −0.5% | −4.6% | 29.0% | 11.2% | 10.2% | 6.1% | 5.7% | 4.5% |
| Free-cash-flow margin | 27.1% | 30.7% | 32.2% | 33.9% | 37.9% | 42.3% | 36.6% | 40.8% | 36.3% | 34.4% | 28.6% | 20.4% | 15.7% | 24.4% | 9.0% | 12.8% | 6.9% | 5.9% |
| Cash flow | ||||||||||||||||||
| Cash from operations | 52 | 61 | 64 | 69 | 81 | 98 | 87 | 102 | 93 | 85 | 72 | 49 | 40 | 57 | 22 | 32 | 18 | 15 |
| Capital spending | 1 | 2 | 2 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 |
| Free cash flow | 51 | 58 | 62 | 69 | 81 | 97 | 87 | 100 | 92 | 84 | 72 | 49 | 39 | 57 | 22 | 31 | 18 | 15 |
| Stock-based pay | — | — | — | — | — | — | — | 0 | 0 | 0 | 2 | 2 | 1 | 1 | 1 | — | — | — |
| Free cash flow after stock pay | — | — | — | — | — | — | — | 100 | 92 | 83 | 70 | 46 | 39 | 56 | 21 | — | — | — |
| Balance sheet | ||||||||||||||||||
| Cash | 49 | 50 | 33 | 56 | 55 | 51 | 83 | 36 | 46 | 45 | 46 | 34 | 27 | 23 | 27 | 29 | 23 | 17 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net debt (negative = net cash) | −49 | −50 | −33 | −56 | −55 | −51 | −83 | −36 | −46 | −45 | −46 | −34 | −27 | −23 | −27 | −29 | −23 | −17 |
| Diluted shares | — | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 51m | 51m | 51m | 51m | — | — | — |
| Returned to shareholders | ||||||||||||||||||
| Buybacks | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 9 | 3 | 1 | 0 | — | — |
| Total returned | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 9 | 3 | 1 | 0 | — | — |
| Quarter | 2024 Q3 Sept 2024 | 2024 Q4 Dec 2024 | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q1 Mar 2026 | 2026 Q2 Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 62 | 63 | 56 | 65 | 63 | 72 | 60 | 60 |
| Net income | 3 | 4 | −2 | 6 | 2 | 7 | 2 | −0 |
| Growth (year on year) | ||||||||
| Revenue | +3.9% | −5.0% | −3.6% | +4.8% | +1.7% | +13.5% | +7.3% | −7.2% |
| Net income | +3.4% | — | −135.7% | +63.1% | −13.4% | +102.7% | — | −106.6% |
| Margins | ||||||||
| Net margin | 4.5% | 5.7% | −2.9% | 9.9% | 3.8% | 10.2% | 3.8% | −0.7% |
| Free-cash-flow margin | 15.1% | 16.9% | 1.2% | 5.1% | 7.3% | 12.5% | −1.1% | 3.3% |
| Cash flow | ||||||||
| Cash from operations | 10 | 11 | 1 | 3 | 5 | 9 | −0 | 2 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | 9 | 11 | 1 | 3 | 5 | 9 | −1 | 2 |
| Last 12 months unless stated | CIA | MFC | FG | GL | JXN | BHF | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $255m | $5.8bn | $6.1bn | $6.2bn | $6.5bn | $6.7bn | $11.1bn |
| Revenue growth, last 12 months | 3.7% | 5.0% | 15.0% | 5.2% | 15.1% | 2.6% | 6.1% |
| Revenue growth, 3-year average | 2.3% | — | 19.4% | 5.5% | 43.4% | 37.8% | 4.9% |
| Revenue growth, latest quarter | −7.2% | — | 4.2% | 8.0% | −22.6% | 86.2% | 6.9% |
| Net margin | 4.5% | 68.5% | 6.9% | 19.6% | 1.6% | 12.5% | 6.5% |
| Cash from operations / revenue | 6.1% | 394.9% | 71.5% | 22.5% | 90.9% | −8.1% | 14.6% |
| Free-cash-flow margin | 5.9% | 390.5% | 59.9% | 19.9% | 90.9% | — | 19.4% |
| Free-cash-flow margin, 3-year average | 8.0% | 152.8% | 86.7% | 22.2% | 106.8% | — | 21.3% |
| Stock pay / revenue | 0.7% | 0.0% | 0.6% | 0.9% | 1.6% | — | 0.8% |
| Change in share count | — | −4.3% | 2.7% | −5.3% | −5.8% | −2.6% | −4.7% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 3.7% | 7.0% | 13 of 18 |
| Change in growth rate Growth | -3.2pp | +1.5pp | 15 of 18 |
| Net margin Profitability | 4.5% | 6.9% | 13 of 18 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| International Insurance | $176M | 69.0% | ▲ 3.0% |
| Domestic Insurance | $79.1M | 31.0% | ▲ 7.6% |
From Citizens, Inc.'s 10-K filed March 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $20.5M | 3.6M | 22.5% | ▲ 9.5% |
| Continental General Insurance Co | $15.2M | 2.6M | 16.6% | ▲ 3.8% |
| Vanguard Capital Management LLC | $11.4M | 2.0M | 12.5% | ▲ 1.5% |
| UBS Group AG | $6.8M | 1.2M | 7.5% | ▲ 83.9% |
| First Eagle Investment Management, LLC | $6.7M | 1.2M | 7.3% | ▲ 100.4% |
| Geode Capital Management, LLC | $6.4M | 1.1M | 7.0% | ▲ 6.5% |
| State Street Corp | $3.8M | 668K | 4.2% | ▼ 0.1% |
| Bridgeway Capital Management, LLC | $2.9M | 513K | 3.2% | ▲ 3.7% |
| Northern Trust Corp | $2.2M | 378K | 2.4% | ▲ 9.6% |
| Vanguard Portfolio Management LLC | $1.8M | 308K | 1.9% | ▲ 18.2% |
| Vanguard Fiduciary Trust Co | $1.7M | 305K | 1.9% | ▲ 5.5% |
| Dimensional Fund Advisors LP | $1.5M | 266K | 1.7% | 0.0% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Citizens, Inc.'s complete shareholder register. Values are as reported by the filers .
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Harwood Michael Philip Director | August 31, 2026 | Buy | 10,000 | $3.80 | $38,000 |
| Stenberg Jon President & CEO | August 11, 2026 | Buy | 12,000 | $3.65 | $43,800 |
| Hoxworth Seth Alan Chief Actuary | August 11, 2026 | Buy | 5,376 | $3.83 | $20,590 |
| Stenberg Jon President & CEO | August 10, 2026 | Buy | 50,000 | $3.99 | $199,500 |
| Stenberg Jon President & CEO | May 21, 2026 | Buy | 10,000 | $4.82 | $48,200 |
| Stenberg Jon President & CEO | March 30, 2026 | Buy | 50,000 | $4.70 | $235,000 |
| Davis Cynthia H Director | March 25, 2026 | Buy | 100 | $4.53 | $453 |
| Stenberg Jon President & CEO | March 17, 2026 | Buy | 10,000 | $4.81 | $48,100 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Next expected around November 6, 2026 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
